Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: A systematic review of clinical trials

Open access

Abstract

Purpose: Brain tumors, particularly glioblastoma multiforme (GBM), present significant prognostic challenges despite multimodal therapies, including surgical resection, chemotherapy, and radiotherapy. One major obstacle is the limited drug delivery across the blood–brain barrier (BBB). Focused ultrasound (FUS) combined with systemically administered microbubbles has emerged as a non-invasive, targeted, and reversible approach to transiently open the BBB, thus enhancing drug delivery. This review examines clinical trials employing BBB opening techniques to optimise pharmacotherapy for brain tumors, evaluates current challenges, and proposes directions for further research. Methods: A systematic literature search was conducted in PubMed and ClinicalTrials.gov up to November 2023, searching for “ultrasound” AND “brain tumor”. The search yielded 1446 results. After screening by title and abstract, followed by full-text screening (n = 48), 35 studies were included in the analysis. Results: Our analysis includes data from 11 published studies and 24 ongoing trials. The predominant focus of these studies is on glioma, including GMB and astrocytoma. One paper investigated brain metastasis from breast cancer. Evidence indicates that FUS facilitates BBB opening and enhances drug uptake following sonication. Exploration of FUS in the pediatric population is limited, with no published studies and only three ongoing trials dedicated to this demographic. Conclusion: FUS is a promising strategy to safely disrupt the BBB, enabling precise and non-invasive lesion targeting, and enhance drug delivery. However, pharmacokinetic studies are required to quantitatively assess improvements in drug uptake. Most studies are phase I clinical trials, and long-term follow-up investigating patient outcomes is essential to evaluate the clinical benefit of this treatment approach. Further studies involving diverse populations and pathologies will be beneficial.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11060-024-04795-z

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic of FUS-Induced BBB Disruption. The application of ultrasound waves to targeted brain region induces microbubble-seeded acoustic cavitation. This process generates intravascular shear stress, leading to reversible changes in BBB permeability, thereby facilitating the enhanced penetration of therapeutic agents into brain tissue. Adapted from “Lipid-Based Microbubbles (MBs) as Ultrasound-Based Drug Delivery System” by BioRender.com (2024). Retrieved from https://app.biorender.com/biorender-templates
Fig. 1 Schematic of FUS-Induced BBB Disruption. The application of ultrasound waves to targeted brain region induces microbubble-seeded acoustic cavitation. This process generates intravascular shear stress, leading to reversible changes in BBB permeability, thereby facilitating the enhanced penetration of therapeutic agents into brain tissue. Adapted from “Lipid-Based Microbubbles (MBs) as Ultrasound-Based Drug Delivery System” by BioRender.com (2024). Retrieved from https://app.biorender.com/biorender-templatesCC BY · PubMed Central
Fig. 2 PRISMA flow chart illustrating the identification and selection process
Fig. 2 PRISMA flow chart illustrating the identification and selection processCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 1

  1. Chang SM, Kuhn JG, Robins HI et al (2001) A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants. Cancer 91:417–422. https://doi.org/10.1002/1097-0142(20010115)91:2%3c417::AID-CNCR1016%3e3.0.CO;2-9 · doi:10.1002/1097-0142(20010115)91:2<417::aid-cncr1016>3.0.co;2-9

Cited by

See all 75

Metadata

Authors
Zhu, H., Allwin, C., Bassous, M. G., & Pouliopoulos, A. N.
Affiliations
King's College London (GB)
Corresponding author
Pouliopoulos, Antonios N.
Venue
Journal of Neuro-Oncology
Published
2024-08-29
Volume
170
Issue
2
Pages
235-252
ISSN
  • 0167-594X (ISSN-L)
  • 1573-7373
OpenAlex
W4402005298
Cited by
75
References
58
Citations by year
2026: 43 · 2025: 32
FWCI
2.69
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neuro-Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Children’s Cancer and Leukaemia Group (CCLG) / Little Princess Trust (CCLGA 2022 25)
  • Action Medical Research / LifeArc (GN3017)
  • Focused Ultrasound Foundation (FUS1050R1)
  • Abbie’s Army / Children’s Brain Tumour Drug Delivery Consortium (KCL/G12/22)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
focused ultrasound, blood-brain barrier opening, brain tumors, glioblastoma, glioma, astrocytoma, brain metastases, breast cancer, microbubbles, drug delivery, clinical trials, pediatric brain tumors
MeSH terms
Antineoplastic Agents, Blood-Brain Barrier, Brain Neoplasms, Clinical Trials as Topic, Humans, Permeability, Ultrasonic Therapy, Drug Delivery Systems, Microbubbles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: A systematic review of clinical trials. https://app.cochat.ai/papers/10.1007/s11060-024-04795-z
The paper
Zhu, H., Allwin, C., Bassous, M. G., & Pouliopoulos, A. N. (2024). Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: A systematic review of clinical trials. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04795-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.